Impact of Splenic Artery Ligation in LDLT for Patients With Portal Hypertension
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
In this study, the investigators aim to prove that performing splenic artery ligation in living donor liver transplantation for patients with portal hypertension is beneficial for early graft function postoperatively. The investigators will be analyzing trend of LFT's (liver function tests) after surgery, time for normalization of bilirubin, INR (international normalised ratio) and decrease in ascites, morbidity, mortality, ICU (intensive care unit) and total hospital stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2021
CompletedFirst Posted
Study publicly available on registry
August 3, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedAugust 17, 2021
August 1, 2021
2 years
July 25, 2021
August 14, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Incidence of early graft dysfunction
Number of patients who develop early graft dysfunction in each group
first postoperative month
Time to normalisation of ascites output
time to normalisation of ascites output (in days)
first postoperative month
Time to normalisation of INR
time to normalisation of INR (in days)
first postoperative month
Time to normalisation of bilirubin
time to normalisation of bilirubin (in days)
first postoperative month
Secondary Outcomes (4)
Morbidity
first postoperative month
ICU stay
first postoperative month
Mortality
first postoperative month
Total hospital stay
first postoperative month
Study Arms (2)
Patients who undergo Splenic artery ligation
EXPERIMENTALIf inclusion criteria are met, these group of patients will undergo splenic artery ligation .
No splenic artery ligation
ACTIVE COMPARATORIf inclusion criteria are met, these group of patients will not undergo splenic artery ligation.
Interventions
Splenic artery will be ligated just after takeoff from coeliac trunk at the level of body of pancreas
Splenic artery is not ligated despite the presence of portal hyperperfusion
Eligibility Criteria
You may qualify if:
- All patients undergoing Living Donor Liver Transplantation(LDLT) accepted according to hospital protocol.
- Patients who have Portal Venous Pressure (PVP) \> 15 mm Hg after reperfusion .
You may not qualify if:
- Patients who have Portal Venous Pressure (PVP) \> 15 mm Hg after reperfusion.
- Patients who had splenectomy.
- Patients who have splenic artery aneurysm.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (7)
Gad EH, Alsebaey A, Lotfy M, Eltabbakh M, Sherif AA. Complications and mortality after adult to adult living donor liver transplantation: A retrospective cohort study. Ann Med Surg (Lond). 2015 Apr 25;4(2):162-71. doi: 10.1016/j.amsu.2015.04.021. eCollection 2015 Jun.
PMID: 26005570BACKGROUNDAbdeldayem H, Kashkoush S, Hegab BS, Aziz A, Shoreem H, Saleh S. Analysis of donor motivations in living donor liver transplantation. Front Surg. 2014 Jul 8;1:25. doi: 10.3389/fsurg.2014.00025. eCollection 2014.
PMID: 25593949BACKGROUNDUmeda Y, Yagi T, Sadamori H, Matsukawa H, Matsuda H, Shinoura S, Mizuno K, Yoshida R, Iwamoto T, Satoh D, Tanaka N. Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation. 2008 Sep 15;86(5):673-80. doi: 10.1097/TP.0b013e318181e02d.
PMID: 18791439BACKGROUNDIto T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y, Hirohashi K, Tanaka AK. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation. 2003 Apr 27;75(8):1313-7. doi: 10.1097/01.TP.0000063707.90525.10.
PMID: 12717222BACKGROUNDJiang SM, Zhou GW, Zhang R, Peng CH, Yan JQ, Wan L, Shen C, Chen H, Li QY, Shen BY, Li HW. Role of splanchnic hemodynamics in liver regeneration after living donor liver transplantation. Liver Transpl. 2009 Sep;15(9):1043-9. doi: 10.1002/lt.21797.
PMID: 19718645BACKGROUNDGarcia-Valdecasas JC, Fuster J, Charco R, Bombuy E, Fondevila C, Ferrer J, Ayuso C, Taura P. Changes in portal vein flow after adult living-donor liver transplantation: does it influence postoperative liver function? Liver Transpl. 2003 Jun;9(6):564-9. doi: 10.1053/jlts.2003.50069.
PMID: 12783396BACKGROUNDWu TJ, Dahiya D, Lee CS, Lee CF, Chou HS, Chan KM, Lee WC. Impact of portal venous hemodynamics on indices of liver function and graft regeneration after right lobe living donor liver transplantation. Liver Transpl. 2011 Sep;17(9):1035-45. doi: 10.1002/lt.22326.
PMID: 21542130RESULT
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 25, 2021
First Posted
August 3, 2021
Study Start
September 1, 2021
Primary Completion
September 1, 2023
Study Completion
October 1, 2023
Last Updated
August 17, 2021
Record last verified: 2021-08